spacer
home > ict > Winter 2013
PUBLICATIONS

International Clinical Trials

ict
Winter 2013

   
Text
PDF
bullet
REGULATORY
Post-Approval Regulation

Priority PASS

Current and planned post-authorisation safety studies across Europe must now take into account revised pharmacovigilance rules, particularly for non-interventional studies. Miranda Dollen at Optum gives the latest.
 
view
download pdf
Trial Regulation

Euro Vision


Europe’s clinical trial regulatory regime faces a shake-up in 2016 in a bid to streamline trial management and cut red tape. Janet Knowles and Carl Fennessy at Eversheds LLP look at the changes on the way.
 
view
download pdf
bullet
Clinical Trial Management
Site Payments

Don’t Take it for Granted

If not done in a standardised manner, processing investigator grant payments can lead to regulatory non-compliance and commercial loss. A globally harmonised approach could make the difference, argues Kevin Williams at CFS Clinical.
 
view
download pdf
Data Management

The Big Picture

Discussing the technological advancements available for investigator sites to assemble and submit data, Abraham Gutman at AG Mednet underlines the importance of proper tools and a validated delivery platform for image-related trials.
 
view
download pdf
Budget Management

Cost Recovery

Kevin Nichols at Isis Pharmaceuticals emphasises the need for an integrated relationship between sponsors and EDC providers to reduce the cost of inevitable changes during trials and speed up product delivery to patients.
 
view
download pdf
CNS Disorders

Central Learning

With CNS disorders posing daunting challenges for 21st century healthcare, Mark Shapiro at Clinipace Worldwide predicts a new research landscape where advances in science, better operational technology and more collaborations bridge the wide gaps in CNS innovation.
 
view
download pdf
Event Review: Partnerships in Clinical Trials Congress

Market Analysis

Current market conditions and strategic alliances were top of the agenda at the recent Partnerships in Clinical Trials Congress. Graham Hughes was there.
 
view
download pdf
Digital Applications

Cyber Security

Mollie Shields-Uehling at SAFE-BioPharma Association discusses a digital identity and digital signature standard for secure authentication and the protection of electronic documents, along with its use in cloud collaboration, collecting hospital patient data and signing off ePrescriptions.

 
view
download pdf
Trial Infrastructure

Get Connected

The costs of investing in internet connectivity and computers for investigator sites are far outweighed by the savings that can be generated in terms of lower cost, reduced timelines and shorter time-to-market, says Martin Stricker at SIRO Clinpharm.
 
view
download pdf
Neurodegenerative Diseases

On Target

MitoTarget, a three-year collaborative proof-of-concept project, is exploring whether mitochondrial dysfunction could be addressed in a trial involving patients with ALS. Rebecca Pruss, Thierry Bordet, Julien Veys and Jean-Louis Abitbol at Trophos report.
 
view
download pdf
Discovery Technology

A New Engine

The future model of drug development needs to embrace a cost- and risk-sharing approach with increased outsourcing. Kevin Lustig and Maria Thompson at Assay Depot debate how a web-based platform for research exchanges is a key step to achieving this.
 
view
download pdf
bullet
Clinical Trial Supply & Packaging
Clinical Ancillaries

The Forgotten Challenge

Transporting clinical ancillaries may seem a minor, albeit crucial, add-on to wider clinical trial logistics, but it is often not given enough consideration. Alex Klim at DHL considers how the supply chain practicalities are getting ever-more complex.
 
view
download pdf
bullet
Regional trials
Translation

Language Barriers?

A multitude of local languages means that there is growing demand for translation services in Africa.But, as Simon Andriesen at MediLingua explains, the lack of suitably trained staff and professional standards are hurdles to overcome.

 
view
download pdf
Focus on MENA

On the Map

The Middle East and North Africa region is projected to be one of the fastest growing markets for clinical research, given its large treatment-naïve population, and the timeline and cost advantages, says Nadia Cheaib at ClinServ.
 
view
download pdf
Regional Development

MENA Reality

Chiheb Guerfel at Poseidon Pharma Services assesses the emerging market potential of the Middle East and North Africa region for clinical trial activities, with its base of qualified graduates and good infrastructure an increasingly attractive prospect.

 
view
download pdf

Interview
Business Insight

Better Together


Craig Lipset of Pfizer is encouraged by the pharma industry’s spirit of collaboration as it looks to accelerate smarter drug development.
 
view
download pdf
Industry Interview

Thinking Allowed

Rahlyn Gossen of Rebar Interactive talks to ICT about her career path, creative solutions and what the coming year has in store.

 
view
download pdf
   
spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August and November

News and Press Releases

CPhI Worldwide to support International Medical Corps UK with global charity partnership


More info >>

White Papers

Faster, Better, Cheaper: Lean as a Driving Force Behind Pharmaceutical Companies’ Growth

TBM Consulting Group

The pharmaceutical industry faces countless challenges: patent expirations, weak product development pipelines, downward pricing pressure and an increasingly burdensome regulatory environment. The most important question for companies is now “How can we position ourselves optimally to be successful in the long term?” Some pharmaceutical companies used the economic downturn in 2009 to embrace measures in the fields of cost reduction and efficiency increases, which can be implemented at short notice. The continuous and consistent implementation of sustainable measures that guarantee stability and form the basis for future growth was not necessarily paramount within this.
More info >>

Industry Events

7th annual Orphan Drugs and Rare Diseases UK

18-19 October 2017, Holiday Inn Kensington Forum, London

SMi Group is thrilled to present the 7th annual Orphan Drugs and Rare Diseases conference, taking place on 18th & 19th October 2017 in Central London, UK. This year’s theme will be focused towards discussing strategies for patient engagement, market access and gene therapies to enhance rare diseases and orphan drug research.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement